Health Rounds: GLP-1 obesity drugs may boost low testosterone
Weight loss from lifestyle changes or bariatric surgery is known to boost testosterone levels, but the impact of anti-obesity medications has not been widely investigated, study leader Dr. Shellsea Portillo Canales of SSM Health St. Louis University Hospital in Missouri said in a statement.
Portillo Canales and colleagues tracked 110 men with obesity – many also with type 2 diabetes – who were being treated with semaglutide, dulaglutide or tirzepatide, the active ingredients in Novo Nordisk's Wegovy and Ozempic or Eli Lilly's Trulicity, Mounjaro, and Zepbound.
The average age was 54. None of the men were receiving other testosterone-boosting medications.
During 18 months of treatment, the proportion of men with testosterone levels in the normal range rose from 53% to 77%.
Testosterone plays a critical role in male sexual functioning but can also impact bone mass, fat distribution, muscle mass, strength and red blood cell production.
In the current study, the greater the weight loss, the greater the improvement in testosterone levels, the researchers found.
While the study cannot prove GLP-1 drugs caused low testosterone levels to normalize, it does show a direct correlation, Portillo Canales noted.
Popular GLP-1 anti-obesity medications are effective for weight loss even when treatment is inconsistent, new findings suggest.
Patients often face challenges in accessing these medications – such as Novo Nordisk's Wegovy and Ozempic and Eli Lilly's Zepbound and Mounjaro - due to supply shortages and insurance coverage obstacles, study leader Kaelen Medeiros of privately held weight-loss company Calibrate in New York said in a statement.
Medeiros and colleagues looked at how interruptions to GLP-1 medication access over the course of two years impacted weight-loss outcomes in 6,392 clients of Calibrate's online metabolic health program. Along with the drugs, the program also included intensive lifestyle interventions and coaching on diet, exercise, sleep and emotional health.
Overall, 72.5% of participants experienced at least one disruption in their GLP-1 treatment and 11.1% had multiple disruptions, Medeiros reported at ENDO 2025.
Participants who faced access issues reported a 13.7% weight loss within 12 months and a 14.9% loss within 24 months, on average. Those without treatment interruptions reported a 17% weight loss in 12 months and 20.1% in 24 months, on average.
Even those who received no more than four treatments over 12 months also achieved clinically significant weight loss, with more than 10% change in body weight on average.
'While unpredictable GLP-1 medication access is frustrating, the good news is that our research shows effective weight loss can still be achieved if paired with appropriate lifestyle changes and coaching support,' Medeiros said.
People who experience a fracture after age 80 might benefit from medications to treat bone deterioration or weakness caused by osteoporosis, researchers reported at the Endocrine Society meeting in San Francisco.
Whether to start osteoporosis drugs at that age has been debated for fear that very elderly patients could be more susceptible to the side effects.
Researchers at the Cleveland Clinic reviewed medical records on 88,676 patients aged 80 and older who had suffered a fracture due to osteoporosis. Half of them had subsequently been treated with either Merck & Co.'s Fosamax, Roche and GlaxoSmithKline's Boniva, Amgen's Prolia, or Eli Lilly's Evista or Forteo.
The others did not receive any osteoporosis drugs.
Over the next five years, after accounting for patients' other health conditions, the hospitalization rate was 19% lower and the mortality rate was 15% lower in the group treated with bone-strengthening medications.
'The results of our study support the need to enhance the individualized initiation of treatment of osteoporosis, even in people who are older than 80,' study leader Dr. Gianina Flocco said in a statement.
'Treating people to reduce the burden of osteoporosis complications, like fractures leading to disability or death, would play a significant role in improving health span in the growing older population.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Reuters
6 hours ago
- Reuters
Wegovy and the future of childhood obesity
Follow on Apple or Spotify. Listen on the Reuters app. Teenagers in the United States are using Wegovy and other weight-loss drugs at quickly rising rates. On this special episode of Reuters World News, we look at the decisions facing parents and children in the battle against childhood obesity. Sign up for the Reuters Econ World newsletter here. Listen to the Reuters Econ World podcast here. Visit the Thomson Reuters Privacy Statement for information on our privacy and data protection may also visit to opt out of targeted advertising. Further Reading The Wegovy effect Wegovy use among US teens up 50% as obesity crisis worsens Weight-loss options for children are hard to come by
Daily Mail
6 hours ago
- Daily Mail
Major UK supermarket launches its own £129-a-month fat jab club - but some shoppers are not impressed
Morrisons has opened its own £129-a-month fat jab club, which has left some shoppers unimpressed. The chain says tirzepatide injections, sold under the brand name Mounjaro, can help users shed up to 20 per cent of their body weight. But this has led to some shoppers pointing out what they perceive as the chain's hypocrisy in selling fatty and sugary food and then in turn charging customers triple figures to help them lose weight, The Sun reports. One shopper said: 'This seems so unethical' whilst another added: 'You can buy your fatty and sugary foods and then a magic jab to make the results go away.' Another called the idea 'genius', saying: 'The store sells you unhealthy grub that gets you fat, then wants vast sums of money to get you thin.' Another added: 'How funny! Stuff your face with a six-pack of doughnuts, a multipack of Walkers crisps, a few sausage rolls followed by a tub of Ben & Jerry's - and then for the privilege of parting with £129 you might lose weight! Oh my days.' On its clinic website, the chain says the self-injectable pen design can be used once a week and to be used consistently. Morrisons Clinic: 'Our approach to weight-loss treatments is based on three core factors, designed with your long-term health as our priority. 'Our expert prescribing pharmacists are specially trained to review, consult and provide medications online. Your healthcare journey is in safe hands. 'Our services are delivered by a team of dedicated pharmacists, prescribers and clinicians.' Morrisons Clinic says the sign-up fee will rise to £159-a-month after the offer period. It comes as previously reported that the UK medicines regulator has launched a probe into the safety of fat jabs after hundreds of Britons developed pancreatitis, leaving ten dead. Officials are examining whether those affected have a genetic trait that leaves them at greater risk of side-effects from the likes of Mounjaro, Wegovy and Ozempic. The Medicines and Healthcare products Regulatory Agency (MHRA) said it has received more than 560 reports of people developing an inflamed pancreas after taking so-called 'GLP-1' injections since they were first launched. Ten cases proved fatal. These drugs are typically known as 'fat jabs' or 'skinny jabs' as they are frequently used for weight management, but some are primarily licensed for the treatment of type 2 diabetes. The MHRA is now calling for users who are admitted to hospital with pancreatitis to report the side effect to authorities using the regulator's Yellow Card scheme. Healthcare workers can also submit a report on patients' behalf. When a Yellow Card report is received, the MHRA will contact patients to ask if they would be willing to take part in the new Biobank study, in collaboration with Genomics England. This would involve providing further information and submitting a saliva sample which will be used to explore whether some people are at a higher risk of acute pancreatitis when taking these medicines due to their genetic makeup.
Scottish Sun
8 hours ago
- Scottish Sun
Fridge-raiding Kim Jong-un 'sparing no expense' to get Ozempic-style drug - but he'll test on guinea pig civilians first
Kim is suspected to suffer from high blood pressure and diabetes, as well as gout FATBOY KIM Fridge-raiding Kim Jong-un 'sparing no expense' to get hands on Ozempic – but he'll test on guinea pig civilians first Click to share on X/Twitter (Opens in new window) Click to share on Facebook (Opens in new window) KIM Jong-un is "sparing no effort or expense" to get his hands on weight-loss drugs after piling the pounds back on, insiders have revealed. It comes as sources told how the North Korean tyrant's obesity-related health problems has forced a shift in his role as Supreme Leader. Sign up for Scottish Sun newsletter Sign up 7 Kim, pictured on July 12, appears to have piled the pounds back on Credit: AFP 7 Kim notably lost a lot of weight in 2021 Credit: EPA 7 Kim and daughter Ju-ae, both centre, visiting the Wonsan Kalma coastal tourist area on June 24 Credit: AFP Wary Kim has now ordered his close confidants to find new medicines abroad to help him trim back, such as Ozempic or a similar drug. Insiders say fridge-raider Kim - who is known to have a legendary appetite - will likely bulk-buy a weight-loss drug before testing it on citizens with a similar figure. One senior North Korea observer said: "If the past is any guide, it is probable that they'd make a bulk purchase. "Because it's a new drug and a new drug to Kim, they might select North Korean citizens with a similar body type and medical history as Kim so they try the drug first for any side effects. "Kim's father, Kim Jong Il, once had some of his aides injected with opiates. "That way, if he became dependent or addicted, they'd all have to detox together." Plump Kim, who stands at just 5ft 6ins, tipped the scales at a whopping 22 stone at his largest before shedding the pounds. Eye-opening images revealed a drastic weight loss in 2021 - but the Supreme Leader has again ballooned to up to over 20 stone. Kim's health has long raised eyebrows - and his love for cigarettes, drinking and imported cheese is a far cry from a healthy diet. North Korea's 'Benidorm' to FINALLY open next week as tyrant Kim Jong-Un cuts ribbon - and Brits have signed up to visit He is suspected to suffer from high blood pressure and diabetes, as well as gout - joint pain linked to a rich diet. Both Kim's father and grandfather died from heart issues, making the dictator likely fearful of the same fate. Michael Madden, founder of NK Leadership Watch, told The Sun: "When we see him in state media reporting, he is often sitting down. "He doesn't walk any great distances, and he uses the car more often to travel short distances at public engagements. "This also raises the question - what has caused the weight gain? "Is it a combination of compulsive stress eating, a sedentary lifestyle and lack of physical activity? Is it a side effect of medication? "If Kim is on medications, do they treat a chronic medical condition that might result in weight gain or metabolism issues? "Then again, do Kim's doctors tell him the truth about his health or conceal a more serious problem?" South Korean spies this month claimed Kim is on the hunt for new weight-loss medicines such as Ozempic from Western countries. And his inner circle will be doing everything they can to get their hands on what their Dear Leader demands. 7 7 Kim shakes hands with Russian culture minister Olga Lyubimova on June 29 Credit: EPA 7 Kim pictured on February 8, 2021, left, and June 15, 2021, right Credit: AP Mr Madden added: "When it comes to the leader's medical treatments, the regime spares no effort or expense to import the best available medicine, medical devices etc, from foreign countries, usually from Central Europe. "If things get pretty dire, the North Koreans will retain foreign physicians and other specialists. "The way this happens is through the Personal Secretariat, which is Kim's executive office as leader and runs his households and domestic life. "The Personal Secretariat has what they call a 'network of correspondents'. "These are elite North Koreans working either in small work teams or as individuals at North Korean embassies or other foreign missions. "They perform a number of discreet tasks on behalf of Kim and some core elites - collecting or interpreting information, making purchases, conducting off the record interactions." Top insiders noted "significant process changes in the regime" as Kim's daughter Ju-ae takes on an "expanding" role - while the dumpy despot takes more of a backseat at events. Kim has yet to anoint an official successor - though his daughter, believed to be 12 or 13, is touted as a strong possibility. When it comes to the leader's medical treatments, the regime spares no effort or expense to import the best available medicine, medical devices etc, from foreign countries, usually from Central Europe Michael Madden One source said: "Restrictions on or disappearing of senior officials from public events is a sign of political transition or regime collapse; in North Korea, it's the former. "The biggest things here are his inaccessibility at public events and the evolving public presence of Ju-ae. "Kim used to be fairly easy to interact with at public events, now they hang back and don't engage as freely as before. "Ju-ae's role and profile have expanded. In the last month, she has started wearing new, more mature clothing. She's starting to resemble her mum. "Ju-ae is also interacting with foreign and DPRK leadership figures more readily." Rumours have also swirled Kim's Gucci-loving daughter Ju-ae is on route to one day take the reins after she was seen accompanying her father at several missile launches. She is regularly presented in carefully controlled state media as his "beloved" and "precious" child - fuelling rumours about her role in the regime in the future. Kim's iron-fist sister Kim Yo-jong, wife Ri Sol ju, brother Kim Jong-chul, his top generals - premier Kim Tok-hun, general Choe Ryong-hae and marshal Pak Jong-chon could also be in the running. A source added: "We are definitely seeing the outliers for succession. "The 10th Party Congress in 2031 will likely be Ju-ae's major debut as a North Korean elite." 7 Kim and his daughter inspect an air force demonstration on November 30, 2023 Credit: AP
